- Home
- AREN vs MXCT Comparison
AREN vs MXCT Comparison
Compare AREN & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AREN | MXCT |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.4M | 160.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AREN | MXCT |
|---|---|---|
| Price | $4.31 | $1.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $7.50 |
| AVG Volume (30 Days) | 103.7K | ★ 597.3K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.66 | N/A |
| Revenue | ★ $142,815,000.00 | $34,419,000.00 |
| Revenue This Year | $13.89 | N/A |
| Revenue Next Year | $13.81 | $10.69 |
| P/E Ratio | $6.56 | ★ N/A |
| Revenue Growth | ★ 6.72 | N/A |
| 52 Week Low | $1.05 | $1.26 |
| 52 Week High | $10.05 | $5.20 |
Technical Indicators
Market Signals| Indicator | AREN | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 29.52 |
| Support Level | $4.11 | $1.48 |
| Resistance Level | $4.41 | $1.59 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 85.12 | 0.00 |
Price Performance
Historical ComparisonAbout AREN The Arena Group Holdings Inc.
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.